Scott B. Vafai

4.3k total citations · 4 hit papers
15 papers, 3.3k citations indexed

About

Scott B. Vafai is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Scott B. Vafai has authored 15 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Clinical Biochemistry and 3 papers in Physiology. Recurrent topics in Scott B. Vafai's work include Mitochondrial Function and Pathology (5 papers), Metabolism and Genetic Disorders (5 papers) and ATP Synthase and ATPases Research (3 papers). Scott B. Vafai is often cited by papers focused on Mitochondrial Function and Pathology (5 papers), Metabolism and Genetic Disorders (5 papers) and ATP Synthase and ATPases Research (3 papers). Scott B. Vafai collaborates with scholars based in United States and Australia. Scott B. Vafai's co-authors include Vamsi K. Mootha, Shao‐En Ong, Steven A. Carr, Sarah E. Calvo, Canny Sugiana, David R. Thorburn, James G. Evans, Betty Chang, Marc Vidal and Avihu Boneh and has published in prestigious journals such as Nature, Cell and Circulation.

In The Last Decade

Scott B. Vafai

15 papers receiving 3.3k citations

Hit Papers

A Mitochondrial Protein Compendium Elucidates Complex I D... 2008 2026 2014 2020 2008 2012 2016 2022 500 1000 1.5k

Peers

Scott B. Vafai
Scott B. Vafai
Citations per year, relative to Scott B. Vafai Scott B. Vafai (= 1×) peers Carina Prip‐Buus

Countries citing papers authored by Scott B. Vafai

Since Specialization
Citations

This map shows the geographic impact of Scott B. Vafai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott B. Vafai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott B. Vafai more than expected).

Fields of papers citing papers by Scott B. Vafai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott B. Vafai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott B. Vafai. The network helps show where Scott B. Vafai may publish in the future.

Co-authorship network of co-authors of Scott B. Vafai

This figure shows the co-authorship network connecting the top 25 collaborators of Scott B. Vafai. A scholar is included among the top collaborators of Scott B. Vafai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott B. Vafai. Scott B. Vafai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rohde, Ellen, Richard Lee, Anne Marie Mazzola, et al.. (2025). † VERVE-102, a clinical stage in vivo base editing medicine, leads to potent and precise inactivation of PCSK9 in preclinical studies. Journal of clinical lipidology. 19(3). e68–e68. 1 indexed citations
3.
Lee, Richard, Anne Marie Mazzola, Maurine Braun, et al.. (2022). Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models. Circulation. 147(3). 242–253. 132 indexed citations breakdown →
4.
To, Tsz‐Leung, Alejandro M. Cuadros, Hardik Shah, et al.. (2019). A Compendium of Genetic Modifiers of Mitochondrial Dysfunction Reveals Intra-organelle Buffering. Cell. 179(5). 1222–1238.e17. 99 indexed citations
5.
Kraft, Guillaume, Melanie Scott, Eric J. Allen, et al.. (2019). Sympathetic Denervation of the Common Hepatic Artery Lessens Glucose Intolerance in the Fat- and Fructose-Fed Dog. Diabetes. 68(6). 1143–1155. 21 indexed citations
6.
Bao, Xiaoyan, Shao‐En Ong, Olga Goldberger, et al.. (2016). Mitochondrial dysfunction remodels one-carbon metabolism in human cells. eLife. 5. 333 indexed citations breakdown →
7.
Vafai, Scott B., Emily Mevers, Jianming Zhang, et al.. (2016). Natural Product Screening Reveals Naphthoquinone Complex I Bypass Factors. PLoS ONE. 11(9). e0162686–e0162686. 19 indexed citations
8.
Lennerz, Belinda, Scott B. Vafai, Nigel F. Delaney, et al.. (2014). Effects of sodium benzoate, a widely used food preservative, on glucose homeostasis and metabolic profiles in humans. Molecular Genetics and Metabolism. 114(1). 73–79. 103 indexed citations
9.
Vafai, Scott B. & Vamsi K. Mootha. (2012). Mitochondrial disorders as windows into an ancient organelle. Nature. 491(7424). 374–383. 543 indexed citations breakdown →
10.
Lieber, Daniel S., Scott B. Vafai, Laura Horton, et al.. (2012). Atypical case of Wolfram syndrome revealed through targeted exome sequencing in a patient with suspected mitochondrial disease. BMC Medical Genetics. 13(1). 3–3. 25 indexed citations
11.
Bhalla, Kavita, Bor Jang Hwang, Ruby E. Dewi, et al.. (2011). PGC1α Promotes Tumor Growth by Inducing Gene Expression Programs Supporting Lipogenesis. Cancer Research. 71(21). 6888–6898. 159 indexed citations
12.
Pagliarini, David J., Sarah E. Calvo, Betty Chang, et al.. (2008). A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology. Cell. 134(1). 112–123. 1571 indexed citations breakdown →
13.
Girnun, Geoffrey D., Liang Chen, Jessica M. Silvaggi, et al.. (2008). Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin. Clinical Cancer Research. 14(20). 6478–6486. 70 indexed citations
14.
Girnun, Geoffrey D., et al.. (2007). Synergy between PPARγ Ligands and Platinum-Based Drugs in Cancer. Cancer Cell. 11(5). 395–406. 109 indexed citations
15.
Vafai, Scott B. & Jeffry B. Stock. (2002). Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer's Disease. FEBS Letters. 518(1-3). 1–4. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026